Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis-Reference-Cited by-同舟云学术

Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis

Published:2022-08 Issue: Volume:173 Page:163-169
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Barry Aisling S.,Helou Joelle,Bezjak Andrea,Wong Rebecca,Dawson Laura A.,Ringash Jolie,Fazelzad Rouhi,Liu Zhihui,Olson Robert,Palma David,Ost Piet,Siva Shankar,Phillips Ryan,Adhikari Neill K.J.

Funder

University of Toronto

Ontario Institute for Cancer Research

Bayer

Varian Medical Systems

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference36 articles.

1. Oligometastases;Hellman;J Clin Oncol,1995

2. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019